Lockdown has been hard on teenagers, but they have shown remarkable adaptation

The COVID-19 lockdown upturned the lives of teenagers at a time when they are usually becoming more independent and taking steps toward their future. Instead, they were confined to their homes, exams were canceled, and their next steps looked suddenly less certain. Our research on the TELL Study – Teenagers’ Experiences of Life in Lockdown—explored […]

Continue Reading

Brain imaging, behavioral data suggest basis for some age-related memory issues

Memory is as much about the future as it is the past. Whether experiencing something new, or something we’ve experienced a hundred times, people use memories of the past to navigate subsequent encounters. Traditionally, psychologists believed that the more ingrained a memory of something was, the more difficult it would be to update your understanding […]

Continue Reading

Diabetic drug could slow the progression of Parkinson’s disease

A hallmark of Parkinson’s disease is the degeneration of a group of dopaminergic neurons in the brain, which play key roles in movement initiation and co-ordination. When these neurons degenerate it leads to akinesia (lack of movement), bradykinesia (slow movement), rigidity and tremor. The effected dopaminergic neurons accumulate a specific protein called alpha synuclein which […]

Continue Reading

World’s first: Drug guides stem cells to desired location, improving their ability to heal

Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy—a scientific first and major advance for the field of regenerative medicine. The discovery, published in the Proceedings of the National Academy of Sciences (PNAS), could improve current stem cell therapies designed […]

Continue Reading

Potential new therapies for Alzheimer’s are revealed through network modeling of its complex molecular interactions

Researchers from Mount Sinai and the National Center for Geriatrics and Gerontology in Japan have identified new molecular mechanisms driving late-onset Alzheimer’s Disease (LOAD), as well as a promising therapeutic candidate for treatment, according to a study in the journal Neuron. LOAD is the most prevalent form of dementia among people over age 65, a […]

Continue Reading